DK217289D0 - Substitueret guanin-nukleosid-derivat, praeparater fremstillet deraf, samt dets anvendelse som laegemiddel - Google Patents

Substitueret guanin-nukleosid-derivat, praeparater fremstillet deraf, samt dets anvendelse som laegemiddel

Info

Publication number
DK217289D0
DK217289D0 DK217289A DK217289A DK217289D0 DK 217289 D0 DK217289 D0 DK 217289D0 DK 217289 A DK217289 A DK 217289A DK 217289 A DK217289 A DK 217289A DK 217289 D0 DK217289 D0 DK 217289D0
Authority
DK
Denmark
Prior art keywords
preparations
medicine
substituted guanine
guanine nucleoside
substituents
Prior art date
Application number
DK217289A
Other languages
English (en)
Other versions
DK217289A (da
DK170780B1 (da
Inventor
Michael Goodman
Robert Chen
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK217289D0 publication Critical patent/DK217289D0/da
Publication of DK217289A publication Critical patent/DK217289A/da
Application granted granted Critical
Publication of DK170780B1 publication Critical patent/DK170780B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK217289A 1988-05-05 1989-05-03 Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, og fremgangsmåde til at forøge en immunreaktion DK170780B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/190,694 US5093318A (en) 1983-11-01 1988-05-05 Immunostimulating guanosine derivatives and their pharmaceutical compositions
US19069488 1988-05-05

Publications (3)

Publication Number Publication Date
DK217289D0 true DK217289D0 (da) 1989-05-03
DK217289A DK217289A (da) 1989-11-06
DK170780B1 DK170780B1 (da) 1996-01-15

Family

ID=22702383

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217289A DK170780B1 (da) 1988-05-05 1989-05-03 Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, og fremgangsmåde til at forøge en immunreaktion

Country Status (12)

Country Link
US (1) US5093318A (da)
EP (1) EP0341066B1 (da)
JP (1) JP2790846B2 (da)
AT (1) ATE113957T1 (da)
AU (1) AU619539B2 (da)
CA (1) CA1320196C (da)
DE (1) DE68919266T2 (da)
DK (1) DK170780B1 (da)
ES (1) ES2063125T3 (da)
GR (1) GR3015018T3 (da)
IE (1) IE66321B1 (da)
PT (1) PT90464B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
US6054441A (en) * 1987-10-28 2000-04-25 Pro-Neuron, Inc. Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
WO1994007904A1 (en) * 1992-10-01 1994-04-14 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
US6727230B1 (en) * 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US5382580A (en) * 1994-05-27 1995-01-17 The Scripps Research Institute N9 morpholino derivatives of 7,8-disubstituted guanines
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5773424A (en) * 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
WO2000062803A2 (en) * 1999-04-15 2000-10-26 Board Of Regents, The University Of Texas System ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US20010044416A1 (en) * 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004448A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
ES2307568T3 (es) * 2000-12-08 2008-12-01 Coley Pharmaceutical Gmbh Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
EP1608403A2 (en) * 2003-04-02 2005-12-28 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations for topical application
BRPI0616385A2 (pt) * 2005-09-22 2011-06-21 Hoffmann La Roche o-acilação seletiva de nucleosìdeos
PL2173376T3 (pl) 2007-08-02 2015-08-31 Biondvax Pharmaceuticals Ltd Multimeryczne wieloepitopowe szczepionki przeciwko grypie
EP2227250A4 (en) 2007-12-03 2011-07-06 Harvard College CHLAMYDIA ANTIGENS
BRPI0922132A2 (pt) 2008-12-03 2018-10-23 Protea Vaccine Tech Ltd fragmentos glutamil trna sintetase (gts).
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
CA2828068C (en) 2011-02-22 2019-03-19 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
EP3492095A1 (en) 2012-04-01 2019-06-05 Technion Research & Development Foundation Limited Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
CN106163553B (zh) 2014-04-03 2021-07-23 彼昂德瓦克斯医药有限公司 多聚体-多表位流感多肽的组合物及其产生
SG11202011667WA (en) 2018-05-25 2020-12-30 Primmune Therapeutics Inc Tlr7 agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948730A (en) * 1982-11-09 1990-08-14 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4539205A (en) * 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods

Also Published As

Publication number Publication date
CA1320196C (en) 1993-07-13
US5093318A (en) 1992-03-03
PT90464B (pt) 1994-12-30
GR3015018T3 (en) 1995-05-31
AU3399989A (en) 1989-11-09
EP0341066A3 (en) 1990-05-30
ATE113957T1 (de) 1994-11-15
ES2063125T3 (es) 1995-01-01
JPH0256496A (ja) 1990-02-26
AU619539B2 (en) 1992-01-30
IE891463L (en) 1989-11-05
DK217289A (da) 1989-11-06
DE68919266T2 (de) 1995-06-01
PT90464A (pt) 1989-11-30
EP0341066B1 (en) 1994-11-09
JP2790846B2 (ja) 1998-08-27
DK170780B1 (da) 1996-01-15
DE68919266D1 (de) 1994-12-15
IE66321B1 (en) 1995-12-27
EP0341066A2 (en) 1989-11-08

Similar Documents

Publication Publication Date Title
DK217289A (da) Substitueret guanin-nukleosid-derivat, praeparater fremstillet deraf, samt dets anvendelse som laegemiddel
ATE109155T1 (de) Immunstimulierende guaninderivate, zusammenstellungen und verfahren.
DK224286A (da) 2',3'-dideoxy-nucleosider
DK0590538T3 (da) Klar hårbehandlingssammensætning, der skal beholdes på, samt fremgangsmåde
LV5624A3 (lv) Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai
FI900412A0 (fi) Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.
PT88400A (pt) Improvements relating to smoking articles
PT88399A (pt) Improvements relating to smoking articles
FI831230L (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
DE69025270D1 (de) Verwendung von Monoolein bei der Behandlung der Periodontal- tasche
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
IT1219857B (it) Composizioni di cura della pelle e metodo per applicarle
DK209187D0 (da) Anvendelse af adenosin-derivater til behandling af demens
DE3586194D1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
FI932759A7 (fi) IL-4:n käyttö rokotteiden immunogeeneihin kohdistuvan immuunireaktion lisäämiseksi
ITMI920886A1 (it) Impiego di oligouretani come agenti di formazione per preparati di pigmenti acquosi
IT8947667A0 (it) Composizione cosmetica per combattere la cellulite
IT1241676B (it) Emulsione stabile sostanzialmente anidra da impiegare come veicolo di una sostanza o composizione nutritiva, cosmetica o terapeutica
ATE36718T1 (de) Glykosaminoglykane verwendbar in kosmetologie.
KR930701470A (ko) 누클레오시드의 인지질 유도체, 이것의 제조방법 및 항바이러스제로서의 사용
IT1234233B (it) Derivati insaturi del benzilidene 3 canfora, procedimento per la loro preparazione e loro impiego come assorbenti di raggi ultravioletti in cosmesi e come intermedi di sintesi di composti organo silicici
KR880009484U (ko) 인형의 머리털의 출몰장치
KR890008265U (ko) 인모가발의 인모구조
IT8302106A0 (it) Lozione per la cura delle alopecie
IT9067037A0 (it) Sedile o piattaforma che puo' essere movimentato per far seguire al corpo il ritmo di una musica.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK